HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Research Seeks Better Understanding Of Talc’s Potential Cancer Link

This article was originally published in The Rose Sheet

Executive Summary

FDA’s Office of Cosmetics and Colors is heading up laboratory studies to explore an issue central to rampant litigation – talc’s effects on female genital system tissues, supported by a grant from the agency’s Office of Women’s Health. The agency is still finalizing a scientific literature review, but expects its research will help fill gaps that have not been adequately covered by epidemiologic and animal studies to date.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel